These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9401277)

  • 21. In leukemic hematopoiesis CD34 antigen does not have the same significance as it does normal hematopoiesis.
    Del Cañizo MC; Galende J; Mota A; Orfao A; Martinez A; Almeida J; San Miguel JF
    Leuk Res; 1997 Jul; 21(7):651-6. PubMed ID: 9301686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia.
    Hans CP; Finn WG; Singleton TP; Schnitzer B; Ross CW
    Am J Clin Pathol; 2002 Feb; 117(2):301-5. PubMed ID: 11863227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.
    Haase D; Feuring-Buske M; Schäfer C; Schoch C; Troff C; Gahn B; Hiddemann W; Wörmann B
    Leukemia; 1997 May; 11(5):674-9. PubMed ID: 9180291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-level expression of a novel epitope of CD59 identifies a subset of CD34+ bone marrow cells highly enriched for pluripotent stem cells.
    Hill B; Rozler E; Travis M; Chen S; Zannetino A; Simmons P; Galy A; Chen B; Hoffman R
    Exp Hematol; 1996 Jul; 24(8):936-43. PubMed ID: 8690053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
    Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of P-glycoprotein in chronic myelogenous leukaemia patients: expression, activity and correlations with CD34 antigen.
    Turkina AG; Baryshnikov AY; Sedyakhina NP; Folomeshkina SV; Sokolova MA; Choroshco ND; Stavrovskaya AA
    Br J Haematol; 1996 Jan; 92(1):88-96. PubMed ID: 8562416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
    Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
    Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
    Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis.
    Lickliter JD; Kratzke RA; Nguyen PL; Niehans GA; Miller JS
    Exp Hematol; 1999 Oct; 27(10):1519-27. PubMed ID: 10517493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia.
    Chávez-González A; Dorantes-Acosta E; Moreno-Lorenzana D; Alvarado-Moreno A; Arriaga-Pizano L; Mayani H
    Arch Med Res; 2014 May; 45(4):343-50. PubMed ID: 24751333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of AC133 vs. CD34 in acute childhood leukemias].
    Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
    Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
    Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
    Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal.
    Nüssler V; Pelka-Fleischer R; Zwierzina H; Nerl C; Beckert B; Gullis E; Gieseler F; Bock S; Bartl R; Petrides PE
    Ann Hematol; 1994; 69 Suppl 1():S25-9. PubMed ID: 7914749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in CD33 intensity between various myeloid neoplasms.
    Jilani I; Estey E; Huh Y; Joe Y; Manshouri T; Yared M; Giles F; Kantarjian H; Cortes J; Thomas D; Keating M; Freireich E; Albitar M
    Am J Clin Pathol; 2002 Oct; 118(4):560-6. PubMed ID: 12375643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
    Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
    Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
    Lanza F; Bi S; Castoldi G; Goldman JM
    Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokines can reduce clonal, CD34-positive cells in acute myeloid leukemia in vitro.
    Braun S; Gerhartz HH; Schmetzer HM
    Ann Hematol; 2000 Jul; 79(7):363-73. PubMed ID: 10965784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DCC protein expression in hematopoietic cell populations and its relation to leukemogenesis.
    Inokuchi K; Miyake K; Takahashi H; Dan K; Nomura T
    J Clin Invest; 1996 Feb; 97(3):852-7. PubMed ID: 8609244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.